| Solid Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived200 of 376show all (up to 200) |
|---|
| → investigated in trials for | Pembrolizumabmonoclonal_antibody 217 trials (103 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 217 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 151 trials (38 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 151 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 140 trials (36 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 140 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 134 trials (23 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 134 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 112 trials (40 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 112 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 108 trials (20 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 108 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 105 trials (27 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 105 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 99 trials (21 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 99 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 98 trials (34 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 98 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 95 trials (41 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 95 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 73 trials (17 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 73 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 64 trials (19 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 64 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 63 trials (21 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 63 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 61 trials (22 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 61 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 55 trials (22 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 55 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 53 trials (27 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 53 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 50 trials (18 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 50 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 48 trials (24 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 48 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall_molecule 47 trials (25 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 47 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 46 trials (16 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 46 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 45 trials (13 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 45 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 41 trials (13 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 41 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 36 trials (22 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 36 trials (14 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 36 trials (5 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 35 trials (11 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 35 trials (4 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 35 trials (19 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 35 trials (12 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fulvestrantsmall molecule 33 trials (18 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall_molecule 33 trials (15 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 32 trials (8 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 32 trials (1 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 30 trials (8 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 29 trials (1 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 29 trials (3 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 28 trials (5 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 27 trials (3 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 25 trials (9 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 24 trials (4 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 23 trials (2 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 23 trials (4 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 22 trials (10 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall molecule 21 trials (3 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 20 trials (6 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 19 trials (4 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 18 trials (8 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 18 trials (8 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall_molecule 18 trials (8 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 18 trials (3 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 18 trials (5 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 18 trials (2 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 18 trials (1 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 17 trials (4 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 17 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 16 trials (7 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 16 trials (12 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selumetinibsmall molecule 16 trials (3 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vemurafenibsmall molecule 16 trials (5 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Eribulinsmall molecule 15 trials (3 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Neratinibsmall molecule 15 trials (5 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 14 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 14 trials (7 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 14 trials (1 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ramucirumabmonoclonal antibody 14 trials (3 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 14 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 13 trials (6 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cobimetinibsmall molecule 13 trials (2 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Entrectinibsmall_molecule 13 trials (8 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinibsmall molecule 13 trials (8 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumabmonoclonal antibody 13 trials (6 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ribociclibsmall molecule 13 trials (7 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 13 trials (1 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 12 trials (1 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 12 trials (3 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 12 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Letrozolesmall molecule 12 trials (4 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 12 trials (8 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 12 trials (4 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 12 trials (5 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axitinibsmall molecule 11 trials (3 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 11 trials (1 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 11 trials (2 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFIRI Regimen 11 trials (3 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 10 trials (6 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 10 trials (3 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 10 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lurbinectedinsmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 10 trials (5 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panitumumabmonoclonal antibody 10 trials (6 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall_molecule 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 10 trials (3 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thiotepasmall molecule 10 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 9 trials (5 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Buparlisibsmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 9 trials (7 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lapatinibsmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retifanlimabmonoclonal antibody 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 9 trials (3 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sotorasibsmall molecule 9 trials (5 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adagrasibsmall_molecule 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alectinibsmall molecule 8 trials (6 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Berzosertibsmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elimusertibsmall molecule 8 trials (4 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX Regimen 8 trials (5 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipatasertibsmall molecule 8 trials (6 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Linifanibsmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumab Emtansineadc 8 trials (6 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alpelisibsmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anti-PD1 Monoclonal Antibody 7 trials (6 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capivasertibsmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Larotrectinibsmall_molecule 7 trials (7 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemigatinibsmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal antibody 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rucaparibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dovitinibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erdafitinibsmall molecule 6 trials (5 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ganitumabmonoclonal antibody 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gefitinibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immune Checkpoint Inhibitor 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Linsitinibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Repotrectinibsmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Serplulimabmonoclonal antibody 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Therapeutic Tumor Infiltrating Lymphocytes 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abirateronesmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvespimycinsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capmatinibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carfilzomibother 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carmustinesmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cixutumumabmonoclonal antibody 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Encorafenibsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzastaurinsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunotherapy 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Infigratinibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lucitanibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Motesanibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | O6-Benzylguaninesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Onalespibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ridaforolimussmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Savolitinibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tamoxifensmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Valproic Acidsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vandetanibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Venetoclaxsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anastrozolesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avapritinibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabazitaxelsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ensartinibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fruquintinibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ixazomibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Megestrolsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mirdametinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mogamulizumabmonoclonal antibody 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Molibresibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Perifosinesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pralatrexatesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pyrotinibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sonidegibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tovorafenibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trabectedinsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tucatinibsmall molecule 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tunlametinibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Arsenic Trioxidesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Barasertibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camonsertibsmall molecule 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Checkpoint Kinase Inhibitor AZD7762 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cytarabinesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dactolisibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Darolutamidesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Denosumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dinaciclibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dordavipronesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Foretinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunomodulatory Oligonucleotide 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Inavolisibsmall molecule 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumab/Nivolumab Regimen 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Solid Neoplasm | 3 | Observed | clinicaltrials | graph → |